|
|
| Year : 2021 | Volume
: 38
| Issue : 4 | Page : 203-209 |
|
| Histopathological review of diagnostic categories of the milan system for reporting salivary gland cytopathology – An institutional experience of 6 years |
|
|
Irem S Isgor1, Selim Yigit Ercetin2, Necati Enver3, Leyla Cinel2
1 Department of Pathology, Sinop Ataturk State Hospital, Sinop, Turkey
2 Department of Pathology, Marmara University School of Medicine, Pendik Research and Training Hospital, Istanbul, Turkey
3 Department of Otolaryngology, Marmara University School of Medicine, Pendik Training and Research Hospital, Istanbul, Turkey
Click here for correspondence address and email
| Date of Submission | 10-Oct-2020 |
| Date of Decision | 29-Jul-2021 |
| Date of Acceptance | 18-Oct-2021 |
| Date of Web Publication | 12-Nov-2021 |
|
|
 |
|
 Abstract | | |
Introduction: Salivary gland malignancies account for 2 to 4% of head and neck cancers. Fine needle aspiration cytology (FNAC) is used in preoperative diagnosis of salivary gland lesions. Although FNAC is a highly reliable technique for preoperative diagnosis, there were no consensus on salivary gland cytopathology reporting. Recently, an international group has recommended a classification system for salivary gland FNAC reporting titled “Milan System for Reporting Salivary Gland Cytopathology” (MSRSGC). In this study, we aimed to evaluate the usability of the Milan System, its ability to determine the risk of malignancy for each category, with comparisons of inital cytologic and final histopathological diagnosis. Materials and Methods: We performed a retrospective analysis of salivary gland lesion FNAC in our department from 2013 to 2019. A total of 578 FNACs were performed in 514 patients. Of these, 85 cases had surgical follow-up (parotid gland, n = 73, submandibular gland, n = 12). The cytological samples were categorized according to the MSRSGC into six categories by two pathologists. The risk of malignancy (ROM) and diagnostic accuracy values were calculated for each diagnostic categories. Results: A total of 85 aspirates of the patients with follow-up, the MSRSGC diagnostic categories were as follows: non-diagnostic in 7 aspirates (8.2%), non-neoplastic in 3 (3.5%), atypia of undetermined significance (AUS) in 9 (10.5%), benign neoplasm in 43 (50.5%), salivary gland neoplasm of undetermined malignant potential in 7 (8.2%), suspicious for malignancy in 10 (11.7%), and malignant in 6 (7%). The ROM for each category was 28, 5%, 0%, 33%, 0%, 28.5%, 90%, and 100%, respectively. Conclusion: FNAC plays a critical role in the evaluation of patients with salivary gland lesions. The MSRSGC helps in the standardization of the process of diagnosis and clinical management of salivary gland lesions, especially of AUS and SUMP categories that are indeterminate categories in nature.
Keywords: AUS, cytology, histopathology, Milan, salivary gland, SUMP
How to cite this article:
Isgor IS, Ercetin SY, Enver N, Cinel L. Histopathological review of diagnostic categories of the milan system for reporting salivary gland cytopathology – An institutional experience of 6 years. J Cytol 2021;38:203-9 |
How to cite this URL:
Isgor IS, Ercetin SY, Enver N, Cinel L. Histopathological review of diagnostic categories of the milan system for reporting salivary gland cytopathology – An institutional experience of 6 years. J Cytol [serial online] 2021 [cited 2023 Mar 27];38:203-9. Available from: https://www.jcytol.org/text.asp?2021/38/4/203/330387 |
| Introduction | |  |
Malignant salivary gland neoplasms account for approximately 3% to 5% of all head and neck cancers.[1] The fine needle aspiration cytology (FNAC) of salivary gland lesions has high sensitivity and predictive potential in the evaluation of salivary gland lesions. It is a rapid, simple, and cost-effective test that can improve the communication between clinicians and pathologists, leading to a consistent approach for the preoperative management of the patients.
Although FNAC for salivary gland cytology is a worldwide established method, there was no classification system available until 2017. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was introduced in 2017 for salivary gland aspirates and the properties for each of the six categories were listed in detail. These categories are listed as non-diagnostic, non-neoplastic, atypia of undetermined significance (AUS), benign neoplasm, salivary gland neoplasm of undetermined malignant potential (SUMP), and suspicious for malignancy (SM) and malignant.[2]
The MSRSGC provides a standardized reporting scheme of salivary gland lesions and standardized clinical management of patients. In our study, we aimed to evaluate the diagnostic accuracy and the risk of malignancy values for each category.
| MaterialS and Methods | | |
The FNAC materials of the cases who presented to our pathology department between 2013 and 2019 were reviewed. The data of 578 FNAC procedures were obtained with repeated aspirates of 514 different patients. Among these, 85 patients underwent surgery in our Head and Neck Surgery Department. In our study, we included cases that underwent surgery and excluded cases that had missing clinical data or radiological data. FNACs usually were performed under ultrasound guidance by a radiologist along with a pathologist. An average of five passes were performed using a 22–23 gauge needle. The aspirated material was ideally spread over two slides; one slide was dried in air and stained with May Grunwald Giemsa stain; the other slide was fixed in alcohol and was stained with Papanicolaou stain. The remaining portion was processed for cell-block preparation that was submerged in a 9:1 mixture of 96% ethyl alcohol and 4% buffered formalin. The cytological specimens that had surgical follow-up were classified based on MSRSGC by two pathologists blinded to the original cytological and histopathological diagnosis.
The risk of malignancy (ROM) and the frequency of each category were determined. The ROM value was determined by dividing the number of cases that were histopathologically diagnosed as malignant in a category to the total number of cases in the same category. To calculate the sensitivity, specificity, positive predictive rate, and negative predictive rate, we divided the cases into benign and malignant groups.
Ethical approval for this study was obtained from the Ethics Committee of Marmara University (reference number-09.2019.858).
| Results | | |
A total of 578 FNAC procedures of 514 patients were performed in our department between 2013 and June 2019. Of these, 85 cases had surgical follow-up. The age of these patients in the surgical follow-up category ranged from 6 to 91 years, with a mean age of 49.09 years. There were 41 females and 44 males. The recategorization of cases according to the Milan System was non-diagnostic in 7 (8.2%), non-neoplastic in 3 (3.5%), AUS in 9 (10.5%), benign neoplasm in 43 (50.5%), SUMP in 7 (8.2%), suspicious for malignancy in 10 (11.7%), and malignant in the remaining 6 (7%) patients [Table 1]. The distribution of cases in these categories with localization and follow-up histopathological diagnosis are presented in [Table 2]. | Table 2: Comparison of MSRSGC diagnoses with histopathological diagnoses and tumour sites
Click here to view |
The calculated ROM for each category were 28.5%, 0%, 33%, 0%, 28.5%, 90%, and 100%, respectively, and these date are presented in [Table 3]. We have also determined the diagnostic accuracy for benign and malignant cases. | Table 3: The risk of malignancy (ROM) according to MSRSGC classification
Click here to view |
| Discussion | | |
In our study, salivary gland lesions were most frequently found in the parotid gland. The age of the cases ranged from 6 to 91 years, consisting of 41 females and 44 males. These data are similar to those reported by previous studies.[3],[4],[5],[6] Viswanathan et al.[4] reported a male:female ratio of 1:1.2 with an age range of 13 to 100 and Rohilla et al.[6] reported a male:female ratio of 1.7:1 with an age range of 1 to 95 years.
Diagnostic sensitivity and specificity in our study were 85.71% and 89.66%, respectively, and these values were generally compatible with previously published values in the literature.[3],[7],[8],[9] Song et al. reported diagnostic sensivity and specifity in malignant cases to be 84.8% and 94.1%, respectively.[7] Hughes et al.[8] had diagnostic sensivity and specifity of 73% and 91%, respectively.
The Milan system suggests non-diagnostic category to represent less than 10% of all cases. In our study, the rate was 8.2% and most of the cases were diagnosed as chronic sialadenitis (28.5%). Kala et al.[9] also reported several cases in this category with chronic sialadenitis as the leading diagnosis. The authors of these recent publications emphasized that there was wide variation among the cases in this category.[5],[9],[10] Wei et al.[5] had 100 cases in non-diagnostic category, and review of histopathological diagnosis revealed that 31% of the cases were non-neoplastic lesions, 44% were benign neoplasms, and 25% were malignant neoplasms. Singh et al.[10] reported three cases in this category with diagnoses of a benign cyst, chronic sialoadenitis, and Whartin tumor.
Our current study had three cases in non-neoplastic category, which represented 3.5% of the total cases. In the literature, again, there was a wide variation among these rates as well.[6],[9],[10],[11],[12]
Rohilla et al.,[6] Kala et al.,[9] Sadullahoglu et al.,[11] and Gaikwad et al.[12] reviewed cases with histopathological correlation and found that non-neoplastic category represented 22.3%, 11.6%, 24.4%, and 31.7% of all their cases, respectively. The rate of non-neoplastic category was higher in studies that had only cytological cases such as Rohilla et al.'s[6] study, which reported 55.8% of non-neoplastic rate, and the lower rate of 3.5% in our study might be due to study design because non-neoplastic cases are not generally excisionally biopsied and our study only included cases that had surgical follow-up.
In our study, two out of three (66.6%) non-neoplastic cases were diagnosed as normal salivary gland tissue and the other as chronic sialoadenitis in histopathological diagnosis. These cases were initially diagnosed as a mass radiologically. Excisions were total submandibular gland exicision at one case and two superficial parotidectomies containing the lesions according to the radiologic and surgical data. Excisions were performed because of radiological–cytological discrepancy. Follow-up of these patients revealed no complaint or any sign of disease.
Histopathological diagnoses of three out of nine total cases (33.3%) in the AUS category were pleomorphic adenoma. In similar studies in the literature, lymphomas are generally the most malignant final diagnosis in this category.[13],[14]
Of the 43 cases in the benign neoplasm category, 31 were diagnosed as pleomorphic adenoma and 11 were diagnosed as Warthin tumor. In previous studies, it was reported that most of the cases in benign neoplasm category were pleomorphic adenoma.[3],[5],[6],[13],[14] This is expected and compatible with our study because pleomorphic adenoma is the most common benign neoplasm of salivary glands.
Moreover, in our study, 8.2% of cases were under the SUMP category. This value was similar to 8.2% and 7.6% that were reported in previous works.[13],[14] There were seven cases in the SUMP category in our study, including three cases of basal cell adenomas. The MRSGCC recommends surgical management in most cases of SUMP.[2] In the following years, if this reporting system is embraced in many other institutes and more studies comparing histopathological diagnosis with cytological data are done, more detailed databases of this category will be available, and thus more reliable results can be achieved.
Furthermore, in our current study, we found SM cases to be 11.2% of all the cases. This value was higher compared to that in other published studies.[7],[9],[15] In their studies that did not have a cytohistopathological correlation, Song, et al.[7] and Kala et al.[9] reported that SM cases accounted for 2.7% and 2.4% of all their total cases, respectively.A rate of 8.5% was reported by Hafez et al.[15], and the study explained this situation by the overestimated rates of surgery due to the cytology reports with atypical and undefined features. Finally, six cases evaluated in the malignant category were the most heterogeneous category, as shown in [Table 2], with variation in histopathological diagnoses. This category represented 7% of all cases in our study and this rate varies in the literature, reported between 19.5% and 9.2%. In the studies of Hafez[15] and Song et al.,[7] ROM values were 100% and 98.5%, respectively, similar to our study.
The ROM value for each category was calculated as 28.5%, 0%, 33%, 0%, 28.5%, 90%, 100%, respectively. The ROM values of similar studies are summarized in [Table 2]. In the study of the Milan group, these rates were found as 25%, 10%, 20%, <5%, 35%, 60%, and 90%, respectively.[2] When compared with other studies, it is seen that although ROM values are 0% in the benign category, this value reaches 100% in the malignant category. It is possible to explain this finding with the fact that the diagnostic criteria are very clear in the “determinate”categories unlike ambiguities of indeterminate categories that cause diagnosic differencies and interobserver variability. Another striking point is the high ROM value in the non-diagnostic category. Non-diagnostic category in the MSRGCC guide is determined as hypocellular or poorly prepared specimens with dense artifacts, specimens containing nonneoplastic salivary gland tissue obtained from a radiologically/clinically mass-forming lesion, and non-mucinous cyst fluids without epithelial component. We used those criteria specified in the guide while evaluating our cases. It was suggested that these cases should comprise less than 10% of all cases.[2] In our study, the non-diagnostic category represented 8.2% of all cases and the ROM value was 28.5%. In management of these cases, the Milan guideline recommends aspiration repetition or a clinico-radiological correlation.[2] Because we only included patients who underwent surgery in our study, the final histopathological diagnoses were as follows: two chronic sialadenitis, one Warthin tumor, one hemangioma, one adenoid cystic carcinoma, one normal salivary gland tissue, and finally one granulocytic sarcoma. When we re-evaluated the aspirate slides of these cases, we found that the slides of both adenoid cystic carcinoma and chronic sialadenitis were insufficient preparations for a diagnosis. The cellular elements in the smears of granulocytic sarcoma and chronic sialadenitis cases were representing normal salivary gland tissue. The aspiration material of the Warthin tumor only had cyst content [Figure 1]a, and re-aspiration was suggested in the pathology report. However, surgical excision was done due to the incompatibility of the pathologic and radiologic data [Figure 1]b. Based on these data and results, we can draw the following conclusion: clinican–pathologist–radiologist communication has to be particularly strong in cases of this category, and in times of insufficient aspiration material or clinical–radiological incompatibility, one should not assume that the lesion was not biopsied as it could very well be representative of the lesion just like of a Warthin tumor cyst content. Or it was and the result is negative for neoplasm like our cases of chronic sialoadenitis and granulocytic sarcoma, which had normal salivary gland tissue on smears. Hence, evaluating the facts and communicating in this situation can be very beneficial. | Figure 1: (a) Case of Warthin non-diagnostic on cytology representing cyst content, PAP (200×), (b). A final histopathological diagnosis of Warthin tumor, (H and E, 100×).
Click here to view |
In the Milan System, “indeterminate” category is divided into two sub-groups: AUS and SUMP. Variable ROM values of “indeterminate categories” in previous studies were observed [Table 4]. Alruwaii et al.[13] emphasized the necessity of clarifying the diagnostic criteria of these categories, especially in the guide, pointing out the variability in their studies. | Table 4: The risk of malignancy (ROM) for each diagnostic category in published other studies
Click here to view |
In the Milan System, AUS is defined as an aspirate that lacks either qualitative or quantitative cytomorphologic features to be diagnosed with confidence as “nonneoplastic or neoplastic.”[2] In our current study, the ROM value for AUS category was 33%. One of the nine cases was diagnosed as mucoepidermoid carcinoma in the final histopathology report [Figure 2]a. A review of the slides [Figure 2]b revealed that the diagnosis of AUS was done due to the presence of atypical cells, but with insufficient cellularity. Two of the nine cases were diagnosed as lymphomas—Hodgkin's lymphoma and MALT lymphoma—in the follow-up. In these two cases, the radiologic appearance of the lesions was suggestive of malignancy with infiltrative borders and increased vascularity. After the AUS diagnosis at cytopathology report with notes of lymphoid rich population, indefinite for lymphoproliferative disorder, physicians performed excision in both cases, revealing that the lesions were intraglandular lymph nodes, affected by MALT and Hodgkin's lymphomas. In the Milan system, it is suggested that slides that are indefinite for neoplasm and slides with reactive atypia, metaplastic changes or mucinous materials with an absent epithelial component should be classified under AUS. Salivary gland lymph nodes or indeterminate lymphoproliferative lesions are also recommended to be included in the AUS category in the Milan system.[2] Previous studies found that one of the most common malignancies in the AUS category was lymphomas.[13],[14] Alruwaii et al.[13] found 7 of 15 malignant cases that were diagnosed as AUS were diagnosed as lymphomas at follow-up. Hollyfield et al.[14] also found similar results in their studies and obtained different data by removing lymphomas from this evaluation. | Figure 2: (a) A final histopathological diagnosis of mucoepidermoid carcinoma, H and E (100×, (b). Case of mucoepidermoid carcinoma on cytology diagnosed as AUS representing just a few atypical cells, PAP stain (200×).
Click here to view |
In light of this knowledge, we recommend that while evaluating monotonous or atypical lymphoid proliferations, if a definitive diagnosis of high-grade lymphoma cannot be made with help of ancillary techniques because it is difficult for cytopathologists, even experienced ones, to rule out low-grade lymphomas on cytomorphological basis. AUS diagnosis should be considered because lymphomas are the major malignant final diagnosis of this category and majority of the false-negative cases as well.
Alruwaii et al.[13] suggested that the rapid on side evaluation (ROSE) technique could be beneficial in the diagnoses of lymphoproliferative lesions. With the ROSE technique, focusing on obtaining cell block material that allows the use of ancillary techniques such as immunohistochemistry, which are of great importance in diagnosis of lymphoproliferative lesions, can also be done. As is known, another technique that is particularly important in lymphoproliferative lesions is the “flow cytometric immunophenotyping.” The MSRSGC guide recommends the use of flow cytometry because it improves the diagnostic value of FNAC in lymphoproliferative lesions.[2] In this study, we used the ROSE technique to collect material for cell blocks, but did not have the opportunity to use flow cytometry on lymphoproliferative lesions.
The other “indeterminate” category is SUMP. It is recommended that this category should be used for cases when a malignant neoplasm cannot be excluded, such as cases with cytologic features implying cellular basaloid neoplasms, cellular oncocytic/oncocytoid neoplasm, and cellular neoplasm with clear cell features. In our study, we found the ROM value for the SUMP category to be 28.5%. The FNAC of a case from a basaloid adenoma [Figure 3]a that was diagnosed as SUMP had rare to a few cohesive cell groups of bland, basaloid-appearing cells with mild nuclear pleomorphism [Figure 3]b. FNAC of another SUMP case from a cellular pleomorphic adenoma had high cellularity, absence of chondromyxoid stroma, accompanied by mild cytologic atypia. | Figure 3: (a) Case of a basaloid adenoma called SUMP on cytology showing uniform basaloid cells, PAP (200×), (b). Basal cell adenoma was composed of bland basaloid cells separated by many abundant amorphous hyaline stroma, H and E (100×).
Click here to view |
In the literature, basaloid neoplasms are reported to be the most common diagnostic problem in salivary gland cytology.[15],[16], [17,[18],[19],[20] In our study, the histopathological diagnoses of four cases, which constituted 57% of the SUMP category, were basal cell lesions. In the final histopathology report, three of them were diagnosed as basal cell adenoma and one was diagnosed as basal cell adenocarcinoma. This finding differs from Liu et al.'s[16] study, which reported a lower rate (7.4%). Viswanathan et al.[4] reported 24% (9/38) of their SUMP cases were basaloid neoplasms. Chen et al.[21] found that 19% (6/31) of their SUMP cases were basaloid neoplasms. Sadullahoglu et al.,[11] reported that only 3 out of 129 (2.3%) and Gargano et al.[22] reported 19 out of their 50 cases (38%) were basaloid neoplasms. Lower number of SUMP cases in our study might have contributed to our higher ratio (57%) of basaloid neoplasms compared to other studies.
In our study, one of the SUMP cases was diagnosed as basal cell adenocarcinoma, and two cases with histopathological diagnosis of basal cell adenoma had initial cytological diagnoses of non-diagnostic and AUS. Cantley et al.[19] and Seethala et al.[23] emphasized that distinction of benign and malignant at cases where a definite diagnosis can not be made should be avoided and descriptive reporting should be done. It is also stated in the Milan system that descriptive reporting can be an ideal approach in cases where specific diagnostic techniques such as immunohistochemistry or molecular studies could not be applied.[2]
In the Milan system, it is recommended that the SM category is to be used in cases where specific criteria for malignancy could not be met.[2] Although the diagnostic criteria for this category are very clear, the expectation to minimize the interobserver variability with the use of ancillary techniques is emphasized. The ROM value for the SM category on previous studies ranges from 60% to 100% [Table 4]. In this regard, while re-evaluating our cases of SM category, lack of cell block material, which we could have been used for ancillary techniques, was noted. We think that cytological diagnosis can be made more clearly with the help of such materials that can be used for ancillary techniques. There was one false-positive case of Warthin tumor, where the initial cytological diagnosis was suspicious for malignancy. Cytological preparations of that case revealed highly cellular slides with pleomorphic cells and the presence of an area suggesting tumor necrosis. Warthin tumors heterogeneity is very well known, because of the overlapping morphological features, and may create challenges at diagnosis.[6]
Finally, very specific definitions have been made in the MRSGCC for the malignant category: “The smears that clearly exhibit malignant morphology with their cytomorphological features” It is also suggested that if possible, exact tumor diagnosis and histological grading should also be reported.[2] The malignant category was the most heterogenous group with six cases, all malignancies had a different kind. Due to the limited number of cases, we did not evaluate the cases by the grades. In the future, molecular techniques might be helpful and more accesible diagnostic tools in each case malignant case.
In conclusion, we think that MSRSGC is a highly functional and practical reporting system in salivary gland cytology. It is also confirmed by the data obtained from previous studies that it can provide standardization in indeterminate categories, where communication with the clinician is of great importance. However, to reach more clear data in terms of standardization of clinical management multicenter, meta-analysis studies with the help of ancillary techniques are required.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Speight PM, AW Barrett. Salivary gland tumours. Oral Dis 2002;8:229-40.  |
| 2. | Faquin WC, Rossi ED, Baloch Z, Barkan GA, Foschini MP, Kurtycz DFI, et al. The Milan System for Reporting Salivary Gland Cytopathology. 1 st ed. Cham, Switzerland: Springer International Publishing AG; 2018. p. 1-182. |
| 3. | Rossi ED, Faquin WC. The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC): An international effort toward improved patient care-when the roots might be inspired by Leonardo da Vinci. Cancer Cytopathol 2018;126:756-66. |
| 4. | Viswanathan K, Sung S, Scognamiglio T, Yang GCH, Siddiqui MT, Rao RA. The role of the Milan system for reporting salivary gland cytopathology: A 5 year institutional experience. Cancer Cytopathol 2018;126:541-51. |
| 5. | Wei S, Layfield LJ, LiVolsi VA, Montone KT, Baloch ZW. Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: A comprehensive review. Diagn Cytopathol 2017;45:8207. |
| 6. | Rohilla M, Singh P, Rajwanshi A, Gupta N, Srinivasan R, Dey P, et al. Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer Cytopathol 2017;125:767-75. |
| 7. | Song SJ, Shafique K, Lawrence QW, Virginia AL, Kathleen TM, Baloch Z. The utility of the Milan System as a risk stratification tool for salivary gland fine needle aspiration cytology specimens. Cytopathology 2019;30:91-8. |
| 8. | Hughes JH, Volk EE, Wilbur DC. Pitfalls in salivary gland fine-needle aspiration cytology: Lessons from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 2005;129:26-31. |
| 9. | Kala C, Kala S, Khan L. Milan system for reporting salivary gland cytopathology: An experience with the implication for risk of malignancy. J Cytol 2019;36:160-4. [ PUBMED] [Full text] |
| 10. | Singh S, Singh P, Auplish R, Khanna SP, Verma K, Aulakh SK. Application of Milan system for reporting of salivary gland pathology and risk stratification: An institutional experience. J Oral Maxillofac Pathol 2020;24:266–72. [Full text] |
| 11. | Sadullahoglu C, Yildirim TH, Nergiz D, Cekic B, Selcuk OT, Osma U, et al. The risk of malignancy according to Milan reporting system of salivary gland fine-needle aspiration with Becton Dickinson SurePath liquid-based processing. Diagn Cytopathol 2019;47:863-8. |
| 12. | Gaikwad VP, Anupriya C, Naik LP. Milan system for reporting salivary gland cytopathology- An Experience from Western Indian Population. J Cytol 2020;37:93-8. [Full text] |
| 13. | Alruwaii F, Hang JF, Zeng BR, Cramer HM, Lai CR, Sancha CD, et al. Risk of malignancy in “Atypia of undetermined significance” category of salivary gland fine-needle aspiration: A bi-institutional experience. Diagn Cytopathol 2020;48:138-43. |
| 14. | Hollyfield JM, O'Connor SM, Maygarden SJ, Greene KG, Scanga LR, Tang S, et al. Northern Italy in the American South: Assessing interobserver reliability within the Milan System for Reporting SalivaryGland Cytopathology. Cancer Cytopathol 2018;126:390-6. |
| 15. | Hafez NH, Abusinna ES. Risk assessment of salivary gland cytological categories of the Milan system: A retrospective cytomorphological and ımmunocytochemical ınstitutional study. Turk Patoloji Derg 2020;36:142-53. |
| 16. | Liu H, Ljungren C, Lin F, Zarka MA, Chen L. Analysis of histologic follow-up and risk of malignancy for salivary gland neoplasm of uncertain malignant potential proposed by the Milan System for Reporting Salivary Gland Cytopathology. Cancer Cytopathol 2018;126:490-7. |
| 17. | Singh S, Singh P, Auplish R, Khanna SP, Verma K, Aulakh SK. Application of Milan system for reporting of salivary gland pathology and risk stratification: An institutional experience. J Oral Maxillofac Pathol 2020;24:266–72. [Full text] |
| 18. | Bhutani N, Sen R, Gupta M, Kataria SP. Moving toward a systematic approach for reporting salivary gland cytopathology: Cytohistological correlation with the application of the Milan system for risk stratification at a tertiary care center. Diagn Cytopathol 2019;47:1125-31. |
| 19. | Cantley RL. Fine-needle aspiration cytology of cellular basaloid neoplasms of the salivary gland. Arch Pathol Lab Med 2019;143:1338-45. |
| 20. | Chakrabarti I, Basu A, Ghosh N. Oncocytic lesion of parotid gland: A dilemma for cytopathologists. J Cytol 2012;29:80-2. [ PUBMED] [Full text] |
| 21. | Chen YA, Wu CY, Yang CS. Application of the Milan system for reporting salivary gland cytopathology: A retrospective study in a tertiary institute. Diagn Cytopathol 2019;47:1160-7. |
| 22. | Gargano SM, Sebastiano C, Solomides CC, Griffith CC, HooKim K. Cytohistologic correlation of basaloid salivary gland neoplasms: Can cytomorphologic classification be used to diagnose and grade these tumors? Cancer Cytopathol 2020;128:92-9. |
| 23. | Seethala RR. Basaloid/blue salivary gland tumors. Mod Pathol 2017;30:S84-95. |
Correspondence Address:
Prof. Leyla Cinel
Department of Pathology, Marmara School of Medicine, Pendik Research and Training Hospital, Istanbul
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/JOC.JOC_193_20
[Figure 1], [Figure 2], [Figure 3]
[Table 1], [Table 2], [Table 3], [Table 4] |
|
| This article has been cited by | | 1 |
Assessment of Risk of Malignancy of Fine-needle Aspiration Cytology in Salivary Gland Lesions Using the Milan System for Reporting Salivary Gland Cytopathology Categorization: A Systematic Review and Meta-analysis |
|
| Amit Kumar, Subhash Chandra, Bishnupati Singh, Swati Sharma, Ankita Tandon, Ajoy Kumar Shahi | | The Journal of Contemporary Dental Practice. 2023; 23(10): 1039 | | [Pubmed] | [DOI] | | | 2 |
Nondiagnostic salivary gland
FNAs
are associated with decreased risk of malignancy compared with “all-comer” patients: Analysis of the Milan System for Reporting Salivary Gland Cytopathology with a focus on Milan I: No |
|
| Shu K. Lui, Troy Tenney, Patrick C. Mullane, Kartik Viswanathan, Daniel J. Lubin | | Cancer Cytopathology. 2022; 130(10): 800 | | [Pubmed] | [DOI] | |
|
|
|
|
|
|
|
|
|
|
|
|
| Article Access Statistics | | | Viewed | 3452 | | | Printed | 52 | | | Emailed | 0 | | | PDF Downloaded | 264 | | | Comments | [Add] | | | Cited by others | 2 | | |
|
|
